BIOSTEM U.S. CORP
company.status.inactiveCIK 1455380fmd_02DEE0F6QW4DSQ81T8EFK7CX2RServices · Services-Personal ServicesTemplate: Standard
Coverage: Mar 01, 2010 to Nov 30, 2012, 10 periods
Latest annual · FY2012
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (3)
- Net income
- (3)
Latest quarter · Q3 FY2013
Millions- Total revenues
- 0
- Gross profit
- 0
- Net income
- (1)
BIOSTEM U.S. CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $94,745 | $14,707 | +544.2% | 10-K 2012-06-01 · proof |
| Gross profit | $56,256 | $13,023 | +332% | 10-K 2012-06-01 · proof |
| Operating income | -$3.3 million | -$179,623 | 10-K 2012-06-01 · proof | |
| Net income | -$3.3 million | -$179,623 | 10-K 2012-06-01 · proof | |
| Cash from operating activities | -$746,071 | -$195,901 | 10-K 2012-06-01 · proof | |
| Total assets | $15,904 | $322,346 | -95.1% | 10-K 2012-06-01 · proof |
| Total liabilities | $90,318 | $64,365 | +40.3% | 10-K 2012-06-01 · proof |
| Cash and cash equivalents | $4,202 | $287,126 | -98.5% | 10-K 2012-06-01 · proof |
- What was BIOSTEM U.S. CORP's revenue in fiscal 2012?
- BIOSTEM U.S. CORP reported revenue of $94,745 for fiscal 2012 (the year ended Feb 29, 2012), against $14,707 the year before (+544.2%). Source: the 10-K filed with the SEC on Jun 1, 2012. SEC
- What was BIOSTEM U.S. CORP's gross profit in fiscal 2012?
- BIOSTEM U.S. CORP reported gross profit of $56,256 for fiscal 2012 (the year ended Feb 29, 2012), against $13,023 the year before (+332%). Source: the 10-K filed with the SEC on Jun 1, 2012. SEC
- What was BIOSTEM U.S. CORP's operating income in fiscal 2012?
- BIOSTEM U.S. CORP reported operating income of -$3.3 million for fiscal 2012 (the year ended Feb 29, 2012), against -$179,623 the year before. Source: the 10-K filed with the SEC on Jun 1, 2012. SEC
- What was BIOSTEM U.S. CORP's net income in fiscal 2012?
- BIOSTEM U.S. CORP reported net income of -$3.3 million for fiscal 2012 (the year ended Feb 29, 2012), against -$179,623 the year before. Source: the 10-K filed with the SEC on Jun 1, 2012. SEC
- What was BIOSTEM U.S. CORP's cash from operating activities in fiscal 2012?
- BIOSTEM U.S. CORP reported cash from operating activities of -$746,071 for fiscal 2012 (the year ended Feb 29, 2012), against -$195,901 the year before. Source: the 10-K filed with the SEC on Jun 1, 2012. SEC
- What are BIOSTEM U.S. CORP's total assets?
- As of Feb 29, 2012, BIOSTEM U.S. CORP reported total assets of $15,904, against $322,346 a year earlier (-95.1%). Source: the 10-K filed with the SEC on Jun 1, 2012. SEC
- What are BIOSTEM U.S. CORP's total liabilities?
- As of Feb 29, 2012, BIOSTEM U.S. CORP reported total liabilities of $90,318, against $64,365 a year earlier (+40.3%). Source: the 10-K filed with the SEC on Jun 1, 2012. SEC
- What are BIOSTEM U.S. CORP's cash and cash equivalents?
- As of Feb 29, 2012, BIOSTEM U.S. CORP reported cash and cash equivalents of $4,202, against $287,126 a year earlier (-98.5%). Source: the 10-K filed with the SEC on Jun 1, 2012. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1455380&period_type=annual&limit=5"Information only, not investment advice.